|Bid||44.13 x 800|
|Ask||44.14 x 1100|
|Day's Range||44.05 - 44.74|
|52 Week Range||28.36 - 61.11|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||14.63|
|Earnings Date||Jan 20, 2021|
|Forward Dividend & Yield||1.68 (3.76%)|
|Ex-Dividend Date||Sep 29, 2020|
|1y Target Est||45.47|
U.S. Bancorp's (USB) business diversification, organic growth and strategic moves continue to drive growth, partly offset by elevated expenses and lack of diversification.
It also generally means higher interest rates on loans, which is good for a bank's bottom line. The United States has gone into recession, Federal Reserve-managed prime interest rates dropped to the 0%-0.25% range, and millions of people were losing their jobs and not spending their money. As we head toward a new year, there have been some recent positive signs for the economy that could bode well for banks, including the fifth-largest bank in the country, U.S. Bancorp (NYSE: USB).
The investor also signals that drug stocks are cheap. And there appears to be a holding of $5 billion or more that has yet to be disclosed.